Biological Aging

4

Review clinical trials related to Biological Aging. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Participants needed: 60
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: OvationLabUpdated: May 29, 2026Locations: 1
Eligibility criteria

Adult females or males age ≥ 40 years [+1]

Current use of a dietary supplement containing fulvic or humic acid [+5]

Status: Not yet recruiting

Translational Initiative to Map Epigenetics in Sleep

The primary aim of TIME-ZZZ is to explore the relationship between chronotype, incidence of depression and biological age, and whether individuals working "out-of-phase" with their chronotype are more likely to exhibit signs of depression and accelerated biological aging.

Participants needed: 10,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Elysium HealthUpdated: Mar 27, 2024
Eligibility criteria

Has taken an INDEX test within the last 3 months [+2]

Consent to participate not given

Status: Recruiting

The Inspire Bio-resource Research Platform for Healthy Aging INSPIRE Platform

Since aging is a systemic (not organ-specific) phenomenon, the main objective of Inspire Bio-resource Research Platform for Healthy Aging is to build a comprehensive research platform gathering biological, clinical (including imaging) and digital resources that will be explored to identify robust (set of) markers of aging, age-related diseases and IC evolution. The Inspire Platform will gather data and biospecimens from subjects of different ages (from 30 years or over - no upper limit for age) and functional capacity levels (from robust to frail to disabled) over 10 years.

Participants needed: 1,000
Trial details
Age: 30+Biological sex: AllType: ObservationalSponsor: University Hospital, ToulouseUpdated: Nov 21, 2023Locations: 1Duration: 10 Years
Eligibility criteria

Aged 30 years-old or over; [+2]

severe disease compromising life expectancy at 5 years; [+1]

Status: Not yet recruiting

The Translational Initiative to Map Epigenetics in Aging (TIME-A)

The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.

Participants needed: 25,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Elysium HealthUpdated: Mar 8, 2023
Eligibility criteria

All adults aged 18 and above [+2]

Consent to participate not given